Latest Mass Tort News and Updates

The first Philadelphia Xarelto bellwether trial, convened in the Philadelphia's Complex Litigation Center, not only went in favor of the plaintiff but also was the first…

On December 5, 2017, a formal nod came in for the formation of Opioid MDL: 2804 by the U.S. Judicial Panel on Multidistrict Litigation. To promote the just and efficient…

<p>Actos (pioglitazone) is an oral diabetes medicine of the thiazolidinedione (TZD) class used to treat Type 2 diabetes. Actos is manufactured by Japanese pharma giant Takeda Pharmaceutical and marketed by Eli Lilly, one of the largest drug…

The U.S. Attorney for Colorado, Jason R. Dunn, announced that Omnicare Inc., a subsidiary of CVS Health, has agreed to compensate $15.3 million in penalties to settle allegations of dispensing…

Abilify (aripiprazole) is an atypical antipsychotic developed by Otsuka Pharmaceutical Co., Ltd. In 1999, Otsuka partnered with Bristol-Myers Squibb (BMS) to complete development, obtain approvals, and market aripiprazole in the U.S. In…

The latest drug to undergo recall due to high levels of the cancer-causing chemical N-Nitrosodimethylamine (NDMA) is metformin, a medication used to control high blood sugar in type-2 diabetes patients.

The Food and Drug Administration (FDA…

A product liability lawsuit was filed against Bristol-Myers Squibb and AstraZeneca by a woman who suffered heart failure and other severe cardiovascular complications alleging to be side effects of the saxagliptin-based diabetes drugs,…

A judge did not allow the Supreme Court June 2017 Bristol-Meyer Plavix ruling influence his decision and allowed the out-of-town plaintiffs from proceeding in state court vaginal mesh and talc powder lawsuits. In June 2017, the U.S. Supreme Court…

The proton-pump inhibitor product liability litigation MDL No. 2757 is witnessing a steady rise in the number of cases filed against the makers alleging they provided false and…

Come June, the first set of Abilify bellwether trials will begin. Judge M. Casey Rodgers presiding over the centralized Abilify litigation is pushing for the parties involved in…